- Efficacy and safety of daratumumab in the treatment of relapsed ...🔍
- Efficacy and Safety of Daratumumab 🔍
- Clinical efficacy of daratumumab monotherapy in patients with ...🔍
- Efficacy and Safety of Daratumumab with Dexamethasone in ...🔍
- Efficacy and safety of daratumumab 🔍
- 3361 Efficacy and Safety of Daratumumab🔍
- Safety and Efficacy of Subcutaneous Daratumumab🔍
- Meta|analysis of the efficacy and safety of daratumumab in the ...🔍
Efficacy and Safety of Daratumumab
Efficacy and safety of daratumumab in the treatment of relapsed ...
Conclusion: Our results suggest that daratumumab-based regimens are effective in the treatment of RRMM, improving progression-free survival, ...
Efficacy and Safety of Daratumumab (DARA) Monotherapy in ...
Efficacy and safety of daratumumab (DARA) monotherapy in patients with intermediate-risk or high-risk smoldering multiple myeloma (SMM): final analysis of the ...
Efficacy and safety of daratumumab in the treatment of relapsed ...
Our results suggest that daratumumab-based regimens are effective in the treatment of RRMM, improving progression-free survival, ...
Clinical efficacy of daratumumab monotherapy in patients with ...
A pooled analysis of 2 daratumumab trials showed no new safety signals, an overall response rate of 31%, and deep and durable responses. Median overall survival ...
Efficacy and Safety of Daratumumab with Dexamethasone in ...
The DARE study assessed the safety and efficacy of daratumumab with dexamethasone in pts with RRMM and severe RI or requiring hemodialysis.
Efficacy and safety of daratumumab (DARA) in pediatric and young ...
We report the initial results of DARA plus VPLD in pediatric and young adult pts with relapsed/refractory T-cell ALL or LL enrolled in the phase 2, open-label ...
Paper: Efficacy and Safety of Daratumumab (DARA) Monotherapy in ...
After a 15.8-month median follow-up, DARA monotherapy showed activity and was well tolerated in pts with intermediate- or high-risk SMM.
3361 Efficacy and Safety of Daratumumab, Pomalidomide ... - Abstract
Conclusion: This is the first and largest reported study of DPd vs DKd for daratumumab naïve patients in a real-world setting. Both DPd and DKd ...
Safety and Efficacy of Subcutaneous Daratumumab | TCRM
SC daratumumab by pharmacokinetic analysis reached a trough dose equivalent to IV daratumumab, qualifying as adequate exposure. At median follow ...
Meta-analysis of the efficacy and safety of daratumumab in the ...
Daratumumab demonstrates promising efficacy in treating multiple myeloma, improving the overall response rate, complete remission, and progression-free ...
Updated subgroup analysis of POLLUX based on cytogenetic risk.
Efficacy and safety of daratumumab, lenalidomide, and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): Updated subgroup analysis of ...
Efficacy and safety of daratumumab, pomalidomide, and ...
We conducted a multicenter retrospective study to analyze the safety and efficacy of DPd versus DKd in daratumumab naïve RRMM patients treated in real-world ...
Efficacy and safety of daratumumab plus bortezomib and ...
Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective ...
Efficacy and safety of daratumumab in the treatment of multiple ...
The available evidence demonstrated that the clinical application of combination regimens containing daratumumab improved the efficacy in patients with MM and ...
Efficacy and Safety of Daratumumab, Bortezomib, and ...
Efficacy and safety of daratumumab, bortezomib, and dexamethasone (D-Vd) versus bortezomib and dexamethasone (Vd) in first relapse patients (pts) with multiple ...
a phase 1, dose-escalation study (MMY1003) - SpringerLink
Daratumumab monotherapy demonstrated favorable safety and efficacy in relapsed/refractory multiple myeloma (RRMM) patients in the global phase 1/2 GEN501 and ...
Daratumumab Plus Standard Therapy for Multiple Myeloma - NCI
A large randomized clinical trial for people newly diagnosed with multiple myeloma has found that adding the drug daratumumab (Darzalex) to a standard ...
Efficacy and Safety of Durvalumab Combined with Daratumumab in ...
Daratumumab is active both as a single agent and in combination with other agents in multiple myeloma (MM) patients. However, the majority of patients will ...
Efficacy and safety of daratumumab with dexamethasone in patients ...
Conclusion: DARA plus dexamethasone was efficacious with a favorable safety profile in pts with RRMM and severe RI or requiring dialysis. Hematologic responses ...
(PDF) Efficacy and safety of daratumumab in the treatment of ...
The available evidence demonstrated that the clinical application of combination regimens containing daratumumab improved the efficacy in patients with MM and ...